ZURICH / LONDON (IT BOLTWISE) – The major Swiss bank UBS has once again confirmed its buy recommendation for Fresenius shares. The company from Bad Homburg has exceeded expectations with its latest business figures and raised its growth targets. Analysts continue to see significant potential in the combination of solid company figures and attractive valuation.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
The major Swiss bank UBS has reiterated its buy recommendation for Fresenius shares after the Bad Homburg company exceeded expectations with its latest business figures. Analysts at the bank continue to see considerable potential in the combination of solid company figures and an attractive valuation with a price-earnings ratio of just 12.
Fresenius has further increased its ambitious growth targets, which was positively received by the analyst community. This development underlines the confidence in the strategic direction of the company, which is characterized by a strong market position and continuous innovation.
UBS’s decision to keep the price target at 57 euros reflects the belief that, despite the challenges in the healthcare sector, Fresenius is well positioned to benefit from long-term trends such as the aging population and increasing demand for healthcare services.
Analysts emphasize that investors with a strategic perspective should keep an eye on Fresenius shares. The company’s solid financial base and ability to adapt to changing market conditions make it an attractive investment target.
Order an Amazon credit card without an annual fee with a credit limit of 2,000 euros!
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ «KI Gadgets»
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “UBS sees great potential in Fresenius shares”.